Literature DB >> 9917841

The significance of matrix metalloproteinases during early stages of tumor progression.

A Lochter1, M D Sternlicht, Z Werb, M J Bissell.   

Abstract

Matrix metalloproteinases (MMPs) orchestrate tissue remodeling and play diverse roles during organ development. They are produced excessively during the course of various pathological conditions, including solid tumors. An important function of MMPs during tumor progression is to provide the proteolytic activity that is necessary both for tumor cells to invade extracellular matrix (ECM) and for neovascularization of tumor tissue by endothelial cells. Recently, independent studies in transgenic animals suggest that MMPs may, in addition, promote very early stages of tumor progression. To investigate this possibility further, we have analyzed the consequences of MMP overexpression in functionally normal and nontumorigenic mouse mammary epithelial cells in culture. Our observations demonstrate that the MMP stromelysin-1 (SL-1) triggers an epigenetic molecular program in mammary epithelial cells that results in a number of phenotypic alterations that eventually culminate in the generation of a malignant tumor-cell phenotype.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9917841     DOI: 10.1111/j.1749-6632.1998.tb10116.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  36 in total

Review 1.  Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones.

Authors:  R K Hansen; M J Bissell
Journal:  Endocr Relat Cancer       Date:  2000-06       Impact factor: 5.678

2.  Patterning and nuclear beta-catenin expression in the colonic adenoma-carcinoma sequence. Analogies with embryonic gastrulation.

Authors:  T Kirchner; T Brabletz
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

3.  Reactive oxygen generated by Nox1 triggers the angiogenic switch.

Authors:  Jack L Arbiser; John Petros; Robert Klafter; Baskaran Govindajaran; Elizabeth R McLaughlin; Lawrence F Brown; Cynthia Cohen; Marsha Moses; Susan Kilroy; Rebecca S Arnold; J David Lambeth
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

Review 4.  Minireview: steroid receptor coactivator-3: a multifarious coregulator in mammary gland metastasis.

Authors:  John P Lydon; Bert W O'Malley
Journal:  Endocrinology       Date:  2010-11-03       Impact factor: 4.736

5.  Reversible Aptamer-Au Plasmon Rulers for Secreted Single Molecules.

Authors:  Somin Eunice Lee; Qian Chen; Ramray Bhat; Shayne Petkiewicz; Jessica M Smith; Vivian E Ferry; Ana Luisa Correia; A Paul Alivisatos; Mina J Bissell
Journal:  Nano Lett       Date:  2015-06-18       Impact factor: 11.189

Review 6.  Fibrosis and cancer: do myofibroblasts come also from epithelial cells via EMT?

Authors:  Derek C Radisky; Paraic A Kenny; Mina J Bissell
Journal:  J Cell Biochem       Date:  2007-07-01       Impact factor: 4.429

7.  Fluorescence detection of MMP-9. I. MMP-9 selectively cleaves Lys-Gly-Pro-Arg-Ser-Leu-Ser-Gly-Lys peptide.

Authors:  Rafal Fudala; Amalendu P Ranjan; Anindita Mukerjee; Jamboor K Vishwanatha; Zygmunt Gryczynski; Julian Borejdo; Pabak Sarkar; Ignacy Gryczynski
Journal:  Curr Pharm Biotechnol       Date:  2011-05       Impact factor: 2.837

8.  Involvement of hnRNP A1 in the matrix metalloprotease-3-dependent regulation of Rac1 pre-mRNA splicing.

Authors:  Federico Pelisch; Davitte Khauv; Guillermo Risso; Melody Stallings-Mann; Matías Blaustein; Leandro Quadrana; Derek C Radisky; Anabella Srebrow
Journal:  J Cell Biochem       Date:  2012-07       Impact factor: 4.429

Review 9.  Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development.

Authors:  Lidiya S Orlichenko; Derek C Radisky
Journal:  Clin Exp Metastasis       Date:  2008-02-20       Impact factor: 5.150

Review 10.  Glial activation and matrix metalloproteinase release in cerebral malaria.

Authors:  A Szklarczyk; M Stins; E A Milward; H Ryu; C Fitzsimmons; D Sullivan; K Conant
Journal:  J Neurovirol       Date:  2007       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.